In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: IDEXX Laboratories trades 41% above its weighted fair value of $415.80, indicating potential overvaluation. Strong profitability and efficiency contrast with Monte Carlo estimates suggesting downside risk and valuation closer to $130-$160. High volatility and a 100% downside risk in scenarios highlight elevated investment risk.